ALR Technologies Inc
OTC:ALRTF

Watchlist Manager
ALR Technologies Inc Logo
ALR Technologies Inc
OTC:ALRTF
Watchlist
Price: 0.0141 USD Market Closed
Market Cap: $9m

ALR Technologies Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ALR Technologies Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
ALR Technologies Inc
OTC:ALRTF
Research & Development
-$499k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.8B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

ALR Technologies Inc
Glance View

Market Cap
9m USD
Industry
Health Care

ALR Technologies, Inc. engages in the provision of remote monitoring and care facilitation for patients with diabetes. The company is headquartered in Richmond, Virginia and currently employs 6 full-time employees. The company went IPO on 2000-03-13. The firm is focused on introducing and marketing its Diabetes Management Solution for medical clinics, hospitals and healthcare providers (HCPs) to provide direct care to patients. Its Diabetes Solution consists of hardware, software and diabetes test supplies. Its ALRT Diabetes Solution is a remote monitoring and care facilitation platform that allows patients to upload the blood glucose data from their blood glucose meters on a weekly basis. The ALRT System processes and converts each data set to a predictive A1C value and shares it with the patient’s physician. The company has also developed the GluCurve Pet continuing glucose monitoring system (CGMS) to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of its Diabetes Solution platform for use by veterinarians in animal health.

ALRTF Intrinsic Value
Not Available

See Also

What is ALR Technologies Inc's Research & Development?
Research & Development
-499k USD

Based on the financial report for Dec 31, 2021, ALR Technologies Inc's Research & Development amounts to -499k USD.

Back to Top